Teva Pharmaceuticals' Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Teva Pharmaceuticals' careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Medical Outcomes Liaison- Ohio **Date:** Feb 16, 2019 **Location:** Detroit, Michigan, US, 48127 **Company:** Teva Pharmaceuticals **Company Info** Teva is a global pharmaceutical leader and the world’s largest ...
Posted: February 17, 2019, 9:00 am
Medical Outcome Liaison- Southeast **Date:** Feb 16, 2019 **Location:** Orlando, Florida, US, 32789 **Company:** Teva Pharmaceuticals **Company Info** Teva is a global pharmaceutical leader and the world’s large...
Posted: February 17, 2019, 9:00 am
Medical Science Liaison- Southern California and Hawaii **Date:** Feb 15, 2019 **Location:** Los Angeles, California, US, 90011 **Company:** Teva Pharmaceuticals **Company Info** Teva is a global pharmaceutical ...
Posted: February 16, 2019, 10:05 am
Senior Trial Master File (TMF) Specialist, Trial Master File (TMF) Governance **Date:** Feb 15, 2019 **Location:** Frazer, Pennsylvania, US, 19355 **Company:** Teva Pharmaceuticals **Company Info** Teva is a glo...
Posted: February 16, 2019, 9:59 am
Manager, Trial Master File (TMF) Governance **Date:** Feb 15, 2019 **Location:** Frazer, Pennsylvania, US, 19355 **Company:** Teva Pharmaceuticals **Company Info** Teva is a global pharmaceutical leader and the ...
Posted: February 16, 2019, 9:59 am

Viewing page 1 of 47|Next Page

  Newsfeed | Subscribe  

In its fourth-quarter earnings investor presentation, Teva Pharmaceutical (TEVA) highlighted a $2.2 billion fall in its spending base from $16.3 billion in 2017 to $14.1 billion in 2018.
Posted: February 19, 2019, 4:58 am
TEL AVIV (Reuters) - Teva Pharmaceutical Industries expects its generic version of Mylan's EpiPen to claim about 25 percent of the U.S. market by the end of the year, CEO Kare Schultz said on Tuesday, ...
Posted: February 19, 2019, 4:20 am
Thus, while TEVA might trade up or down, and might work out well for shareholders in the fullness of time, my updated analysis of this name leads me to again comment on where my pharmaceutical ...
Posted: February 19, 2019, 1:47 am
Teva Pharmaceutical (NYSE:TEVA) expects its generic version of Mylan's (NASDAQ:MYL) EpiPen to have about 25% share of the U.S. market by the end of 2019. The company is already selling its product ...
Posted: February 19, 2019, 1:40 am
The coming year will continue to be challenging for Israeli drug giant Teva Pharmaceuticals, CEO Kare Schultz said Tuesday, but the company is meeting its ambitious cost-cutting and wholesale restruct...
Posted: February 19, 2019, 1:37 am

Viewing page 1 of 3|Next Page